MethylScan is a new low-cost cell-free DNA methylome test that removes much of the healthy blood DNA background, helping rare ...

After putting 12 different air purifier models in a smoke chamber, we found the best one for capturing viruses so you don't ...

Lung cancer remains the leading cause of cancer-related deaths worldwide, accounting for nearly one in five cancer deaths - around 1.8 million lives lost each year.

A third of patients with connective tissue disease-associated interstitial lung disease developed progressive pulmonary fibrosis.

Detroit Pistons star point guard Cade Cunningham has been diagnosed with a collapsed lung and will be re-evaluated in two weeks, per the team. The news came after ESPN's Shams Charania reported ...

RecordCyPath® LungRevenue and Unit Sales. Revenue from our noninvasive diagnostic for lung cancer increased 87% over 2024 with the number of tests performed rising 99% year over year, reflecting ...

CyPath® Lung test supported recommendation for surveillance strategy, rather than subjecting elderly patient to an invasive, risky and costly biopsy procedure Despite a suspicious nodule during a ...

bioAffinity Technologies, Inc.(Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today released a new clinical case study in ...

New Case Study Highlights Ability of bioAffinity Technologies’ CyPath® Lung to Reduce Diagnostic Burden for Patients At Risk for Lung Cancer CyPath® Lung test supported recommendation for surveillance ...

SAN ANTONIO, Texas--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today ...

bioAffinity Technologies, Inc.(Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today announced a new clinical case study ...